140 related articles for article (PubMed ID: 21965472)
1. Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma.
Alvarez R; Dupuis J; Plonquet A; Christov C; Copie-Bergman C; Hemery F; Gaillard I; El Gnaoui T; Kuhnowski F; Bedoui M; Belhadj K; Brugières P; Haioun C
Ann Oncol; 2012 May; 23(5):1274-1279. PubMed ID: 21965472
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
Sancho JM; Orfao A; Quijano S; García O; Panizo C; Pérez-Ceballos E; Deben G; Salar A; González-Barca E; Alonso N; García-Vela JA; Capote J; Peñalver FJ; Provencio M; Arias J; Plaza J; Caballero D; Morado M; Feliu E; Ribera JM;
Eur J Haematol; 2010 Oct; 85(4):321-8. PubMed ID: 20528905
[TBL] [Abstract][Full Text] [Related]
3. Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome.
Muñiz C; Martín-Martín L; López A; Sánchez-González B; Salar A; Almeida J; Sancho JM; Ribera JM; Heras C; Peñalver FJ; Gómez M; González-Barca E; Alonso N; Navarro B; Olave T; Sala F; Conde E; Márquez JA; Cabezudo E; Cladera A; García-Malo M; Caballero MD; Orfao A;
Blood; 2014 Mar; 123(12):1864-9. PubMed ID: 24501214
[TBL] [Abstract][Full Text] [Related]
4. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.
Tawfik B; Brown L; Fuda F; Chen W; Niu S; Sailors J; Sadeghi N
Ann Hematol; 2018 Sep; 97(9):1707-1716. PubMed ID: 29680874
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
[TBL] [Abstract][Full Text] [Related]
6. [Clinical diagnostic significance of cerebrospinal fluid detection with flow cytometry in children acute lymphoblastic leukemia accompanied by central nervous system leukemia].
Yang WY; Wang HJ; Chen YM; Chen XJ; Zou Y; Guo Y; Wang SC; Liu TF; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):38-42. PubMed ID: 22391161
[TBL] [Abstract][Full Text] [Related]
7. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.
Quijano S; López A; Manuel Sancho J; Panizo C; Debén G; Castilla C; Antonio García-Vela J; Salar A; Alonso-Vence N; González-Barca E; Peñalver FJ; Plaza-Villa J; Morado M; García-Marco J; Arias J; Briones J; Ferrer S; Capote J; Nicolás C; Orfao A;
J Clin Oncol; 2009 Mar; 27(9):1462-9. PubMed ID: 19224854
[TBL] [Abstract][Full Text] [Related]
8. Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination.
Benevolo G; Stacchini A; Spina M; Ferreri AJ; Arras M; Bellio L; Botto B; Bulian P; Cantonetti M; Depaoli L; Di Renzo N; Di Rocco A; Evangelista A; Franceschetti S; Godio L; Mannelli F; Pavone V; Pioltelli P; Vitolo U; Pogliani EM;
Blood; 2012 Oct; 120(16):3222-8. PubMed ID: 22927246
[TBL] [Abstract][Full Text] [Related]
9. Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry.
Wudhikarn K; Bunworasate U; Julamanee J; Lekhakula A; Chuncharunee S; Niparuck P; Ekwattanakit S; Khuhapinant A; Norasetthada L; Nawarawong W; Makruasi N; Kanitsap N; Sirijerachai C; Chansung K; Wong P; Numbenjapon T; Prayongratana K; Suwanban T; Wongkhantee S; Praditsuktavorn P; Intragumtornchai T;
Ann Hematol; 2017 Jan; 96(1):57-64. PubMed ID: 27752821
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
Oka S; Ono K; Nohgawa M
Pathol Oncol Res; 2020 Jul; 26(3):1843-1850. PubMed ID: 31768966
[TBL] [Abstract][Full Text] [Related]
12. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.
Del Principe MI; Buccisano F; Cefalo M; Maurillo L; Di Caprio L; Di Piazza F; Sarlo C; De Angelis G; Irno Consalvo M; Fraboni D; De Santis G; Ditto C; Postorino M; Sconocchia G; Del Poeta G; Amadori S; Venditti A
Ann Hematol; 2014 Sep; 93(9):1509-13. PubMed ID: 24752416
[TBL] [Abstract][Full Text] [Related]
14. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.
Wilson WH; Bromberg JE; Stetler-Stevenson M; Steinberg SM; Martin-Martin L; Muñiz C; Sancho JM; Caballero MD; Davidis MA; Brooimans RA; Sanchez-Gonzalez B; Salar A; González-Barca E; Ribera JM; Shovlin M; Filie A; Dunleavy K; Mehrling T; Spina M; Orfao A
Haematologica; 2014 Jul; 99(7):1228-35. PubMed ID: 24727817
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.
Villa D; Connors JM; Sehn LH; Gascoyne RD; Savage KJ
Haematologica; 2011 Jul; 96(7):1002-7. PubMed ID: 21486867
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Sasagawa Y; Akai T; Tachibana O; Iizuka H
J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
[TBL] [Abstract][Full Text] [Related]
17. Critical role of multidimensional flow cytometry in detecting occult leptomeningeal disease in newly diagnosed aggressive B-cell lymphomas.
Di Noto R; Scalia G; Abate G; Gorrese M; Pascariello C; Raia M; Morabito P; Capone F; Pardo CL; Mirabelli P; Mariotti E; Del Vecchio L
Leuk Res; 2008 Aug; 32(8):1196-9. PubMed ID: 18262645
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.
Gleeson M; Counsell N; Cunningham D; Chadwick N; Lawrie A; Hawkes EA; McMillan A; Ardeshna KM; Jack A; Smith P; Mouncey P; Pocock C; Radford JA; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Ann Oncol; 2017 Oct; 28(10):2511-2516. PubMed ID: 28961838
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience.
Shimazu Y; Notohara K; Ueda Y
Int J Hematol; 2009 Jun; 89(5):577-83. PubMed ID: 19353238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
